InvestorsHub Logo
icon url

volgoat

09/13/12 8:59 PM

#92237 RE: biopharm #92235

Immunotherapy-

Amgen paid $1.6B to acquire. PHII single arm, few patients-

http://www.thepharmaletter.com/file/113466/72-complete-response-in-ph-ii-leukemia-study-of-amgens-blinatumomab.html